The Latest Breaking News from biotechnology

The biotechnology sector is witnessing a surge in investor optimism as companies like Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) continue to outperform market expectations. Amid a backdrop of growing demand for innovative treatments, Alnylam’s recent performance highlights the company’s strong position in the competitive landscape.

Abivax SA (NASDAQ:ABVX) stock is skyrocketing on Wednesday after the clinical-stage biotechnology company announced overwhelmingly positive topline results from its Phase 3 ABTECT-1 (Study 105) and ABTECT-2 (Study 106) 8-week induction trials for oral obefazimod (ABX464) in adult patients with moderately to severely active ulcerative colitis.

Zhengye Biotechnology Holding (NASDAQ:ZYBT) shares are trading lower after the company announced it received a Nasdaq noncompliance notice.

What are BioTechnology industry experts saying about AI? How will it impact future tech?

William and the actress visited labs in Norwich where Colorifix, a biotechnology firm, creates its textile dyes.

Fungi are nature’s recyclers and chemists, turning waste into useful products and creating an array of enzymes and compounds. By harnessing this potential through fungal biotechnology (using fungi to develop products and technologies for various applications), we can create sustainable materials, food and processes that help solve global challenges like…

Have you been hearing about the dire wolf lately? Maybe you saw a massive white wolf on the cover of Time magazine or a photo of “Game of Thrones” author George R.R. Martin holding a puppy named after a character from his books.

Moderna has significantly underperformed other biotechnology stocks over the past year, and analysts remain cautious on the stock’s prospects.

Analysts are uber bullish on Actuate Therapeutics and PDS Biotechnology stocks for the next 12 months. Here’s why.